PDL
AZN icon

Portfolio Design Labs’s AstraZeneca AZN Stock Holding History

Portfolio Design Labs’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$231K Hold
1,220
– – 0.04% 219
2026
Q1 		$241K Buy
+1,220
New +$235K 0.04% 194
2025
Q3 		– Sell
-1,716
Closed -$240K – 202
2025
Q2 		$240K Buy
1,716
+337
+24% +$47.2K 0.05% 137
2025
Q1 		$203K Sell
1,379
-309
-18% -$44.7K 0.04% 188
2024
Q4 		$221K Buy
+1,688
New +$236K 0.05% 185

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Portfolio Design Labs's AZN Position: Q2 2026 in Review

Portfolio Design Labs held its AstraZeneca (AZN) position steady in Q2 2026 at 1,220 shares worth $231K. The position accounts for 0.04% of the portfolio, ranked #219.

Portfolio Design Labs first reported a position in AZN in Q4 2024 and has held it in 5 quarters since. The position peaked at $241K in Q1 2026. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Portfolio Design Labs held 1,220 shares of AstraZeneca worth $231K as of Q2 2026.
  • Portfolio Design Labs left its AstraZeneca share count unchanged in Q2 2026.
  • AstraZeneca made up 0.04% of Portfolio Design Labs's portfolio in Q2 2026, its #219 holding.
  • Portfolio Design Labs first reported a position in AstraZeneca in Q4 2024 and has held it in 5 quarters since.
  • Portfolio Design Labs's AstraZeneca position peaked at $241K in Q1 2026.
  • 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Portfolio Design Labs's 13F filing for Q2 2026, filed 11 Aug 2026.